explore
Previous article:
Duchenne breakthrough therapy leaves behind pioneering families
Next article: A disappointing year of Humira biosimilars
Next article: A disappointing year of Humira biosimilars
Wikipedia
explore
-
Readout LOUD podcast: Live from the 2023 STAT Summit
2025-09-27 18:00 -
Readout LOUD podcast: Live from the 2023 STAT Summit
2025-09-27 17:40 -
Gilead acquiring CymaBay and its liver disease drug for $4.3 billion
2025-09-27 17:29 -
Key House Republican on health care plans exit from Congress
2025-09-27 16:56 -
Private equity deals in Medicare Advantage declines
2025-09-27 16:26 -
What we’ve learned from the Aduhelm mess
2025-09-27 16:16